Kratos: Strong Backlog and Awards Defend Premium, but Cash Conversion Remains the Proving Ground

What happened

Despite a sharp 2026 share-price decline, Kratos Defense has amassed a $2.0 billion backlog, $1.46 billion funded, and delivered a 1.6x book-to-bill in Q1, supporting management's view that second-half revenue will significantly exceed the first half. The company's equity-fueled balance sheet—$1.46 billion cash and zero debt—eliminates solvency risk, but the stock still trades at over 70x EBITDA, capitalizing production growth before free cash flow turns positive. Dilution from recent equity raises has increased the share count by roughly 22% in 18 months, meaning per-share economics lag headline EV and EBITDA growth. The near-term catalyst is clear: Q2 and Q3 must show funded backlog climbing above $1.46 billion and operating cash flow turning positive to validate the ramp. If those proof points emerge, the premium can hold; if not, the stock faces further de-rating.

Implication

Kratos is a high-conviction buy only if backlog conversion accelerates in 2H26, funded backlog exceeds $1.55B, and cash flow turns positive; otherwise, the shares remain overvalued relative to near-term cash generation.

Thesis delta

The thesis has shifted from a drone-concept story to a prove-the-ramp execution story, where the market now demands visible backlog conversion and cash improvement rather than just award headlines. While the DeepValue report remains cautious with a WAIT rating, the Seeking Alpha article highlights that strong backlog and margin-accretive mix justify a cautious Buy. The delta is that near-term funded backlog growth and cash flow inflection are now the decisive factors, making the stock a high-stakes binary on 2H26 operational performance.